Asylum Announces Ben Ohler as AFM Business Manager
News May 30, 2013
Asylum Research has announced the appointment of Dr. Ben Ohler to the new position of Atomic Force Microscopy (AFM) Business Manager.
Ohler will oversee the Asylum MFP-3D family of products as well as manage the strategic direction, new product development, and product marketing for the entire line.
“We are very excited that Ben has joined the Asylum Research team,” commented Roger Proksch, President of Asylum Research.
Proksch continued, “Ben brings with him numerous years of AFM and product line management experience which will enable and accelerate our continuing growth. Ben also has an excellent applications background, so he understands the needs of researchers. He can take this knowledge and translate it to new product development that will allow us to continue our technological leadership while also expanding into new and emerging markets. I might add, he has hit the ground running and with only a few months at Asylum, Ben has successfully led the launch of our new MFP-3D Origin™ AFM.”
“I’m thrilled to be with Asylum Research,” added Ohler. “It’s fantastic to be a part of a team so utterly committed and passionate about producing the highest performance and highest quality AFMs and providing a truly unequalled standard of customer support. I’m looking forward to contributing to our continued growth.”
Before joining Asylum, Dr. Ohler held the position of Product Line Manager within the AFM group of Bruker (previously Veeco) for five years and Applications and Development Scientist for eight years.
He received his Ph.D. in Chemical Engineering from the University of California Santa Barbara where his research focused on the biophysics of neurodegenerative disorders.
He has numerous peer-reviewed publications and is a co-author on five patents in the field of AFM.
Pathway in Neurons may Contribute to Neurodegenerative DiseaseNews
Pathway has received attention as potential drug target.READ MORE
Some 30,000 Biomedical Publications Report on Misidentified CellsNews
Researchers from Radboud University have found more than 30,000 publications are reporting on the wrong cells.